Steroids and antibiotics for severe infections in HIV patients
Part of Infections clinical trials.
This trial tests if adding steroids and stronger antibiotics can help people with HIV who are very sick from an infection. The goal is to find better treatment for those not getting better with standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and living with HIV
- You are in the hospital with a serious infection and have signs like low blood pressure, fast breathing, or confusion
- You live in a specific area so the study team can follow up with you
- You agree to use effective birth control if you could become pregnant
- You do not have active tuberculosis or are being treated for it
- You are not pregnant or breastfeeding
- You do not have severe liver disease or drink more than a moderate amount of alcohol
- You are not already taking steroid medications or drugs that can interfere with TB treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This trial tests a new “triple-dose” set of medicines to treat people whose tuberculosis (TB) has come back in the lungs. If you qualify, the goal is to improve cure rates and reduce the chance of TB returning again.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This Phase 3 trial tests whether adding doxycycline to standard TB medicine can improve lung function and reduce lung tissue damage. It aims to see if patients recover better by targeting the lung response to TB.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.